nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A7—Temsirolimus—kidney cancer	0.0825	0.129	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0825	0.129	CbGbCtD
Fluticasone Propionate—CYP3A5—Temsirolimus—kidney cancer	0.0619	0.0964	CbGbCtD
Fluticasone Propionate—CYP3A4—Everolimus—kidney cancer	0.0357	0.0556	CbGbCtD
Fluticasone Propionate—CYP3A7—Paclitaxel—kidney cancer	0.0283	0.0441	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0283	0.0441	CbGbCtD
Fluticasone Propionate—CYP3A7—Sorafenib—kidney cancer	0.0252	0.0392	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0252	0.0392	CbGbCtD
Fluticasone Propionate—CYP3A7—Vincristine—kidney cancer	0.0244	0.038	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0244	0.038	CbGbCtD
Fluticasone Propionate—CYP3A4—Temsirolimus—kidney cancer	0.0241	0.0376	CbGbCtD
Fluticasone Propionate—CYP3A5—Erlotinib—kidney cancer	0.0232	0.0361	CbGbCtD
Fluticasone Propionate—CYP3A5—Paclitaxel—kidney cancer	0.0212	0.0331	CbGbCtD
Fluticasone Propionate—CYP3A7—Sunitinib—kidney cancer	0.0204	0.0317	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0204	0.0317	CbGbCtD
Fluticasone Propionate—CYP3A5—Sorafenib—kidney cancer	0.0189	0.0294	CbGbCtD
Fluticasone Propionate—NR3C2—collecting duct of renal tubule—kidney cancer	0.0184	0.277	CbGeAlD
Fluticasone Propionate—CYP3A5—Vincristine—kidney cancer	0.0183	0.0285	CbGbCtD
Fluticasone Propionate—CYP3A5—Sunitinib—kidney cancer	0.0153	0.0238	CbGbCtD
Fluticasone Propionate—CYP3A4—Pazopanib—kidney cancer	0.0127	0.0197	CbGbCtD
Fluticasone Propionate—CYP3A4—Erlotinib—kidney cancer	0.00905	0.0141	CbGbCtD
Fluticasone Propionate—CYP3A4—Paclitaxel—kidney cancer	0.00828	0.0129	CbGbCtD
Fluticasone Propionate—NR3C2—nephron—kidney cancer	0.00819	0.123	CbGeAlD
Fluticasone Propionate—CYP3A4—Sorafenib—kidney cancer	0.00736	0.0115	CbGbCtD
Fluticasone Propionate—CYP3A4—Vinblastine—kidney cancer	0.00727	0.0113	CbGbCtD
Fluticasone Propionate—CYP3A4—Vincristine—kidney cancer	0.00714	0.0111	CbGbCtD
Fluticasone Propionate—CYP3A4—Sunitinib—kidney cancer	0.00596	0.00928	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—kidney cancer	0.00446	0.00695	CbGbCtD
Fluticasone Propionate—NR3C1—urine—kidney cancer	0.00352	0.053	CbGeAlD
Fluticasone Propionate—CYP3A4—urine—kidney cancer	0.00266	0.0401	CbGeAlD
Fluticasone Propionate—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00231	0.0348	CbGeAlD
Fluticasone Propionate—SERPINA6—nephron tubule—kidney cancer	0.00216	0.0326	CbGeAlD
Fluticasone Propionate—PLA2G4A—renal system—kidney cancer	0.00198	0.0297	CbGeAlD
Fluticasone Propionate—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.00198	0.0297	CbGeAlD
Fluticasone Propionate—SERPINA6—renal system—kidney cancer	0.00197	0.0296	CbGeAlD
Fluticasone Propionate—SERPINA6—kidney—kidney cancer	0.0019	0.0286	CbGeAlD
Fluticasone Propionate—PLA2G4A—cortex of kidney—kidney cancer	0.00186	0.028	CbGeAlD
Fluticasone Propionate—SERPINA6—cortex of kidney—kidney cancer	0.00185	0.0279	CbGeAlD
Fluticasone Propionate—NR3C2—nephron tubule—kidney cancer	0.00177	0.0266	CbGeAlD
Fluticasone Propionate—Amcinonide—ANXA1—kidney cancer	0.00177	0.443	CrCbGaD
Fluticasone Propionate—NR3C2—renal system—kidney cancer	0.00161	0.0242	CbGeAlD
Fluticasone Propionate—NR3C2—kidney—kidney cancer	0.00155	0.0234	CbGeAlD
Fluticasone Propionate—NR3C2—cortex of kidney—kidney cancer	0.00151	0.0228	CbGeAlD
Fluticasone Propionate—NR3C2—cardiac atrium—kidney cancer	0.00144	0.0217	CbGeAlD
Fluticasone Propionate—CYP3A5—nephron tubule—kidney cancer	0.000955	0.0144	CbGeAlD
Fluticasone Propionate—NR3C1—nephron tubule—kidney cancer	0.000948	0.0143	CbGeAlD
Fluticasone Propionate—CYP3A5—renal system—kidney cancer	0.000868	0.0131	CbGeAlD
Fluticasone Propionate—NR3C1—renal system—kidney cancer	0.000862	0.013	CbGeAlD
Fluticasone Propionate—CYP3A5—kidney—kidney cancer	0.00084	0.0126	CbGeAlD
Fluticasone Propionate—NR3C1—kidney—kidney cancer	0.000833	0.0125	CbGeAlD
Fluticasone Propionate—CYP3A5—cortex of kidney—kidney cancer	0.000818	0.0123	CbGeAlD
Fluticasone Propionate—NR3C1—cortex of kidney—kidney cancer	0.000811	0.0122	CbGeAlD
Fluticasone Propionate—NR3C1—gonad—kidney cancer	0.000773	0.0116	CbGeAlD
Fluticasone Propionate—NR3C1—cardiac atrium—kidney cancer	0.000772	0.0116	CbGeAlD
Fluticasone Propionate—CYP3A4—renal system—kidney cancer	0.000652	0.00981	CbGeAlD
Fluticasone Propionate—CYP3A4—kidney—kidney cancer	0.00063	0.00949	CbGeAlD
Fluticasone Propionate—Dexamethasone—ANXA1—kidney cancer	0.000555	0.139	CrCbGaD
Fluticasone Propionate—Triamcinolone—BCHE—kidney cancer	0.00034	0.0852	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—CYP1A1—kidney cancer	0.000319	0.08	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—ABCB1—kidney cancer	0.000198	0.0497	CrCbGaD
Fluticasone Propionate—Pruritus—Everolimus—kidney cancer	0.000164	0.000721	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Vincristine—kidney cancer	0.000163	0.00072	CcSEcCtD
Fluticasone Propionate—Oedema—Vincristine—kidney cancer	0.000163	0.00072	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Paclitaxel—kidney cancer	0.000163	0.000719	CcSEcCtD
Fluticasone Propionate—Infection—Vincristine—kidney cancer	0.000162	0.000715	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Capecitabine—kidney cancer	0.000162	0.000715	CcSEcCtD
Fluticasone Propionate—Chest pain—Gemcitabine—kidney cancer	0.000162	0.000713	CcSEcCtD
Fluticasone Propionate—Arthralgia—Gemcitabine—kidney cancer	0.000162	0.000713	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Doxorubicin—kidney cancer	0.000161	0.000708	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000161	0.000708	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Vincristine—kidney cancer	0.00016	0.000706	CcSEcCtD
Fluticasone Propionate—Mental disorder—Paclitaxel—kidney cancer	0.00016	0.000705	CcSEcCtD
Fluticasone Propionate—Discomfort—Gemcitabine—kidney cancer	0.00016	0.000704	CcSEcCtD
Fluticasone Propionate—Urticaria—Sorafenib—kidney cancer	0.000159	0.000703	CcSEcCtD
Fluticasone Propionate—Erythema—Paclitaxel—kidney cancer	0.000159	0.000701	CcSEcCtD
Fluticasone Propionate—Malnutrition—Paclitaxel—kidney cancer	0.000159	0.000701	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vinblastine—kidney cancer	0.000159	0.0007	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Sorafenib—kidney cancer	0.000159	0.000699	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Sorafenib—kidney cancer	0.000159	0.000699	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Everolimus—kidney cancer	0.000158	0.000697	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Sunitinib—kidney cancer	0.000158	0.000696	CcSEcCtD
Fluticasone Propionate—Pruritus—Erlotinib—kidney cancer	0.000158	0.000696	CcSEcCtD
Fluticasone Propionate—Methylprednisolone—ABCB1—kidney cancer	0.000158	0.0396	CrCbGaD
Fluticasone Propionate—Epistaxis—Capecitabine—kidney cancer	0.000157	0.000694	CcSEcCtD
Fluticasone Propionate—Triamcinolone—PTGS2—kidney cancer	0.000157	0.0393	CrCbGaD
Fluticasone Propionate—Pain—Dactinomycin—kidney cancer	0.000156	0.000689	CcSEcCtD
Fluticasone Propionate—Eczema—Doxorubicin—kidney cancer	0.000155	0.000685	CcSEcCtD
Fluticasone Propionate—Oedema—Gemcitabine—kidney cancer	0.000155	0.000683	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Gemcitabine—kidney cancer	0.000155	0.000683	CcSEcCtD
Fluticasone Propionate—Infection—Gemcitabine—kidney cancer	0.000154	0.000679	CcSEcCtD
Fluticasone Propionate—Dizziness—Vinblastine—kidney cancer	0.000154	0.000677	CcSEcCtD
Fluticasone Propionate—Dizziness—Everolimus—kidney cancer	0.000153	0.000674	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Paclitaxel—kidney cancer	0.000153	0.000674	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Sunitinib—kidney cancer	0.000153	0.000673	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Sunitinib—kidney cancer	0.000153	0.000673	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Erlotinib—kidney cancer	0.000153	0.000673	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Gemcitabine—kidney cancer	0.000152	0.00067	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Dactinomycin—kidney cancer	0.000151	0.000664	CcSEcCtD
Fluticasone Propionate—Skin disorder—Gemcitabine—kidney cancer	0.000151	0.000664	CcSEcCtD
Fluticasone Propionate—Vision blurred—Paclitaxel—kidney cancer	0.00015	0.00066	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00015	0.000659	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Capecitabine—kidney cancer	0.000149	0.000657	CcSEcCtD
Fluticasone Propionate—Tremor—Paclitaxel—kidney cancer	0.000149	0.000657	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000149	0.000656	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Capecitabine—kidney cancer	0.000149	0.000656	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Sorafenib—kidney cancer	0.000148	0.000652	CcSEcCtD
Fluticasone Propionate—Vomiting—Vinblastine—kidney cancer	0.000148	0.000651	CcSEcCtD
Fluticasone Propionate—Dizziness—Erlotinib—kidney cancer	0.000148	0.00065	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Paclitaxel—kidney cancer	0.000148	0.00065	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Capecitabine—kidney cancer	0.000147	0.000649	CcSEcCtD
Fluticasone Propionate—Vomiting—Everolimus—kidney cancer	0.000147	0.000648	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Doxorubicin—kidney cancer	0.000146	0.000644	CcSEcCtD
Fluticasone Propionate—Agitation—Paclitaxel—kidney cancer	0.000146	0.000644	CcSEcCtD
Fluticasone Propionate—Rash—Everolimus—kidney cancer	0.000146	0.000643	CcSEcCtD
Fluticasone Propionate—Dermatitis—Everolimus—kidney cancer	0.000146	0.000642	CcSEcCtD
Fluticasone Propionate—Headache—Vinblastine—kidney cancer	0.000145	0.000641	CcSEcCtD
Fluticasone Propionate—Angioedema—Paclitaxel—kidney cancer	0.000145	0.00064	CcSEcCtD
Fluticasone Propionate—Headache—Everolimus—kidney cancer	0.000145	0.000639	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dactinomycin—kidney cancer	0.000145	0.000637	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dactinomycin—kidney cancer	0.000145	0.000637	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000144	0.000636	CcSEcCtD
Fluticasone Propionate—Malaise—Paclitaxel—kidney cancer	0.000143	0.000632	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Sunitinib—kidney cancer	0.000142	0.000627	CcSEcCtD
Fluticasone Propionate—Pruritus—Sorafenib—kidney cancer	0.000142	0.000626	CcSEcCtD
Fluticasone Propionate—Vomiting—Erlotinib—kidney cancer	0.000142	0.000625	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000141	0.000622	CcSEcCtD
Fluticasone Propionate—Rash—Erlotinib—kidney cancer	0.000141	0.00062	CcSEcCtD
Fluticasone Propionate—Dermatitis—Erlotinib—kidney cancer	0.000141	0.000619	CcSEcCtD
Fluticasone Propionate—Palpitations—Paclitaxel—kidney cancer	0.00014	0.000619	CcSEcCtD
Fluticasone Propionate—Eye disorder—Capecitabine—kidney cancer	0.00014	0.000617	CcSEcCtD
Fluticasone Propionate—Headache—Erlotinib—kidney cancer	0.00014	0.000616	CcSEcCtD
Fluticasone Propionate—Pain—Vincristine—kidney cancer	0.00014	0.000616	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Capecitabine—kidney cancer	0.000139	0.000613	CcSEcCtD
Fluticasone Propionate—Cough—Paclitaxel—kidney cancer	0.000139	0.000611	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Gemcitabine—kidney cancer	0.000138	0.000609	CcSEcCtD
Fluticasone Propionate—Nausea—Vinblastine—kidney cancer	0.000138	0.000608	CcSEcCtD
Fluticasone Propionate—Nausea—Everolimus—kidney cancer	0.000137	0.000605	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Sorafenib—kidney cancer	0.000137	0.000605	CcSEcCtD
Fluticasone Propionate—Hypertension—Paclitaxel—kidney cancer	0.000137	0.000605	CcSEcCtD
Fluticasone Propionate—Pruritus—Sunitinib—kidney cancer	0.000137	0.000602	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Capecitabine—kidney cancer	0.000135	0.000597	CcSEcCtD
Fluticasone Propionate—Chest pain—Paclitaxel—kidney cancer	0.000135	0.000597	CcSEcCtD
Fluticasone Propionate—Arthralgia—Paclitaxel—kidney cancer	0.000135	0.000597	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Capecitabine—kidney cancer	0.000135	0.000595	CcSEcCtD
Fluticasone Propionate—Anxiety—Paclitaxel—kidney cancer	0.000135	0.000595	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—kidney cancer	0.000135	0.000594	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Dactinomycin—kidney cancer	0.000135	0.000594	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000134	0.000592	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Capecitabine—kidney cancer	0.000134	0.00059	CcSEcCtD
Fluticasone Propionate—Discomfort—Paclitaxel—kidney cancer	0.000134	0.000589	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Vincristine—kidney cancer	0.000134	0.000589	CcSEcCtD
Fluticasone Propionate—Dizziness—Sorafenib—kidney cancer	0.000133	0.000585	CcSEcCtD
Fluticasone Propionate—Pain—Gemcitabine—kidney cancer	0.000133	0.000584	CcSEcCtD
Fluticasone Propionate—Nausea—Erlotinib—kidney cancer	0.000133	0.000584	CcSEcCtD
Fluticasone Propionate—Dry mouth—Paclitaxel—kidney cancer	0.000132	0.000583	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Sunitinib—kidney cancer	0.000132	0.000582	CcSEcCtD
Fluticasone Propionate—Mental disorder—Capecitabine—kidney cancer	0.000131	0.000579	CcSEcCtD
Fluticasone Propionate—Erythema—Capecitabine—kidney cancer	0.00013	0.000575	CcSEcCtD
Fluticasone Propionate—Malnutrition—Capecitabine—kidney cancer	0.00013	0.000575	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Paclitaxel—kidney cancer	0.00013	0.000572	CcSEcCtD
Fluticasone Propionate—Oedema—Paclitaxel—kidney cancer	0.00013	0.000572	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Vincristine—kidney cancer	0.000129	0.000569	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Vincristine—kidney cancer	0.000129	0.000569	CcSEcCtD
Fluticasone Propionate—Infection—Paclitaxel—kidney cancer	0.000129	0.000568	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—kidney cancer	0.000128	0.0322	CrCbGaD
Fluticasone Propionate—Dizziness—Sunitinib—kidney cancer	0.000128	0.000563	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Gemcitabine—kidney cancer	0.000128	0.000563	CcSEcCtD
Fluticasone Propionate—Vomiting—Sorafenib—kidney cancer	0.000128	0.000563	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Paclitaxel—kidney cancer	0.000127	0.000561	CcSEcCtD
Fluticasone Propionate—Tachycardia—Paclitaxel—kidney cancer	0.000127	0.000558	CcSEcCtD
Fluticasone Propionate—Rash—Sorafenib—kidney cancer	0.000127	0.000558	CcSEcCtD
Fluticasone Propionate—Dermatitis—Sorafenib—kidney cancer	0.000126	0.000557	CcSEcCtD
Fluticasone Propionate—Skin disorder—Paclitaxel—kidney cancer	0.000126	0.000556	CcSEcCtD
Fluticasone Propionate—Headache—Sorafenib—kidney cancer	0.000126	0.000554	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Capecitabine—kidney cancer	0.000125	0.000553	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dactinomycin—kidney cancer	0.000125	0.000551	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—kidney cancer	0.000125	0.00055	CcSEcCtD
Fluticasone Propionate—Vision blurred—Capecitabine—kidney cancer	0.000123	0.000542	CcSEcCtD
Fluticasone Propionate—Vomiting—Sunitinib—kidney cancer	0.000123	0.000541	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Gemcitabine—kidney cancer	0.000123	0.00054	CcSEcCtD
Fluticasone Propionate—Tremor—Capecitabine—kidney cancer	0.000122	0.000539	CcSEcCtD
Fluticasone Propionate—Rash—Sunitinib—kidney cancer	0.000122	0.000537	CcSEcCtD
Fluticasone Propionate—Dermatitis—Sunitinib—kidney cancer	0.000122	0.000536	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—kidney cancer	0.000122	0.000536	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Capecitabine—kidney cancer	0.000121	0.000534	CcSEcCtD
Fluticasone Propionate—Headache—Sunitinib—kidney cancer	0.000121	0.000533	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—kidney cancer	0.000121	0.000532	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Vincristine—kidney cancer	0.00012	0.000531	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP1A1—kidney cancer	0.000119	0.0299	CrCbGaD
Fluticasone Propionate—Nausea—Sorafenib—kidney cancer	0.000119	0.000526	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000118	0.000521	CcSEcCtD
Fluticasone Propionate—Malaise—Capecitabine—kidney cancer	0.000118	0.000519	CcSEcCtD
Fluticasone Propionate—Vomiting—Dactinomycin—kidney cancer	0.000116	0.000512	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—kidney cancer	0.000116	0.000512	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Paclitaxel—kidney cancer	0.000116	0.00051	CcSEcCtD
Fluticasone Propionate—Palpitations—Capecitabine—kidney cancer	0.000115	0.000508	CcSEcCtD
Fluticasone Propionate—Rash—Dactinomycin—kidney cancer	0.000115	0.000508	CcSEcCtD
Fluticasone Propionate—Nausea—Sunitinib—kidney cancer	0.000115	0.000506	CcSEcCtD
Fluticasone Propionate—Cough—Capecitabine—kidney cancer	0.000114	0.000502	CcSEcCtD
Fluticasone Propionate—Hypertension—Capecitabine—kidney cancer	0.000113	0.000496	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000112	0.000494	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vincristine—kidney cancer	0.000112	0.000493	CcSEcCtD
Fluticasone Propionate—Arthralgia—Capecitabine—kidney cancer	0.000111	0.00049	CcSEcCtD
Fluticasone Propionate—Chest pain—Capecitabine—kidney cancer	0.000111	0.00049	CcSEcCtD
Fluticasone Propionate—Pain—Paclitaxel—kidney cancer	0.000111	0.000489	CcSEcCtD
Fluticasone Propionate—Anxiety—Capecitabine—kidney cancer	0.000111	0.000488	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00011	0.000486	CcSEcCtD
Fluticasone Propionate—Discomfort—Capecitabine—kidney cancer	0.00011	0.000484	CcSEcCtD
Fluticasone Propionate—Pruritus—Gemcitabine—kidney cancer	0.00011	0.000483	CcSEcCtD
Fluticasone Propionate—Betamethasone—ABCB1—kidney cancer	0.000109	0.0273	CrCbGaD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—kidney cancer	0.000109	0.00048	CcSEcCtD
Fluticasone Propionate—Dry mouth—Capecitabine—kidney cancer	0.000109	0.000479	CcSEcCtD
Fluticasone Propionate—Nausea—Dactinomycin—kidney cancer	0.000109	0.000479	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—kidney cancer	0.000108	0.000477	CcSEcCtD
Fluticasone Propionate—Dizziness—Vincristine—kidney cancer	0.000108	0.000476	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—kidney cancer	0.000108	0.000474	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—kidney cancer	0.000108	0.000474	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Paclitaxel—kidney cancer	0.000107	0.000471	CcSEcCtD
Fluticasone Propionate—Oedema—Capecitabine—kidney cancer	0.000106	0.000469	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000106	0.000468	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Gemcitabine—kidney cancer	0.000106	0.000467	CcSEcCtD
Fluticasone Propionate—Infection—Capecitabine—kidney cancer	0.000106	0.000466	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—kidney cancer	0.000105	0.000461	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Capecitabine—kidney cancer	0.000104	0.00046	CcSEcCtD
Fluticasone Propionate—Tachycardia—Capecitabine—kidney cancer	0.000104	0.000458	CcSEcCtD
Fluticasone Propionate—Vomiting—Vincristine—kidney cancer	0.000104	0.000458	CcSEcCtD
Fluticasone Propionate—Skin disorder—Capecitabine—kidney cancer	0.000103	0.000456	CcSEcCtD
Fluticasone Propionate—Urticaria—Paclitaxel—kidney cancer	0.000103	0.000454	CcSEcCtD
Fluticasone Propionate—Rash—Vincristine—kidney cancer	0.000103	0.000454	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vincristine—kidney cancer	0.000103	0.000454	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Paclitaxel—kidney cancer	0.000103	0.000452	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Paclitaxel—kidney cancer	0.000103	0.000452	CcSEcCtD
Fluticasone Propionate—Headache—Vincristine—kidney cancer	0.000102	0.000451	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—kidney cancer	0.000102	0.000447	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—kidney cancer	0.000101	0.000445	CcSEcCtD
Fluticasone Propionate—Vomiting—Gemcitabine—kidney cancer	9.85e-05	0.000434	CcSEcCtD
Fluticasone Propionate—Rash—Gemcitabine—kidney cancer	9.77e-05	0.000431	CcSEcCtD
Fluticasone Propionate—Dermatitis—Gemcitabine—kidney cancer	9.76e-05	0.00043	CcSEcCtD
Fluticasone Propionate—Headache—Gemcitabine—kidney cancer	9.71e-05	0.000428	CcSEcCtD
Fluticasone Propionate—Nausea—Vincristine—kidney cancer	9.7e-05	0.000428	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.7e-05	0.000428	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—kidney cancer	9.61e-05	0.000424	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—kidney cancer	9.59e-05	0.000423	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Paclitaxel—kidney cancer	9.56e-05	0.000421	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—kidney cancer	9.49e-05	0.000418	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Capecitabine—kidney cancer	9.49e-05	0.000418	CcSEcCtD
Fluticasone Propionate—Nausea—Gemcitabine—kidney cancer	9.21e-05	0.000406	CcSEcCtD
Fluticasone Propionate—Pruritus—Paclitaxel—kidney cancer	9.18e-05	0.000405	CcSEcCtD
Fluticasone Propionate—Pain—Capecitabine—kidney cancer	9.11e-05	0.000401	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—kidney cancer	9.03e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—kidney cancer	8.97e-05	0.000395	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Paclitaxel—kidney cancer	8.88e-05	0.000391	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Capecitabine—kidney cancer	8.77e-05	0.000387	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—kidney cancer	8.73e-05	0.000385	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Capecitabine—kidney cancer	8.71e-05	0.000384	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—kidney cancer	8.71e-05	0.000384	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—kidney cancer	8.63e-05	0.00038	CcSEcCtD
Fluticasone Propionate—Dizziness—Paclitaxel—kidney cancer	8.58e-05	0.000378	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—kidney cancer	8.46e-05	0.000373	CcSEcCtD
Fluticasone Propionate—Urticaria—Capecitabine—kidney cancer	8.46e-05	0.000373	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Capecitabine—kidney cancer	8.42e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Capecitabine—kidney cancer	8.42e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—kidney cancer	8.41e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—kidney cancer	8.41e-05	0.000371	CcSEcCtD
Fluticasone Propionate—Vomiting—Paclitaxel—kidney cancer	8.25e-05	0.000364	CcSEcCtD
Fluticasone Propionate—Rash—Paclitaxel—kidney cancer	8.18e-05	0.000361	CcSEcCtD
Fluticasone Propionate—Dermatitis—Paclitaxel—kidney cancer	8.17e-05	0.00036	CcSEcCtD
Fluticasone Propionate—Headache—Paclitaxel—kidney cancer	8.13e-05	0.000358	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—kidney cancer	8.09e-05	0.000356	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—kidney cancer	7.93e-05	0.000349	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Capecitabine—kidney cancer	7.85e-05	0.000346	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—kidney cancer	7.8e-05	0.000344	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—kidney cancer	7.73e-05	0.000341	CcSEcCtD
Fluticasone Propionate—Nausea—Paclitaxel—kidney cancer	7.71e-05	0.00034	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—kidney cancer	7.58e-05	0.000334	CcSEcCtD
Fluticasone Propionate—Pruritus—Capecitabine—kidney cancer	7.53e-05	0.000332	CcSEcCtD
Fluticasone Propionate—Dexamethasone—PTGS2—kidney cancer	7.46e-05	0.0187	CrCbGaD
Fluticasone Propionate—Palpitations—Doxorubicin—kidney cancer	7.43e-05	0.000328	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—kidney cancer	7.34e-05	0.000323	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Capecitabine—kidney cancer	7.29e-05	0.000321	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—kidney cancer	7.26e-05	0.00032	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—kidney cancer	7.16e-05	0.000316	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—kidney cancer	7.16e-05	0.000316	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—kidney cancer	7.14e-05	0.000314	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.11e-05	0.000313	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—kidney cancer	7.07e-05	0.000312	CcSEcCtD
Fluticasone Propionate—Dizziness—Capecitabine—kidney cancer	7.04e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—kidney cancer	7e-05	0.000309	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—kidney cancer	6.86e-05	0.000303	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—kidney cancer	6.86e-05	0.000303	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—kidney cancer	6.82e-05	0.000301	CcSEcCtD
Fluticasone Propionate—Vomiting—Capecitabine—kidney cancer	6.77e-05	0.000298	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—kidney cancer	6.73e-05	0.000297	CcSEcCtD
Fluticasone Propionate—Rash—Capecitabine—kidney cancer	6.71e-05	0.000296	CcSEcCtD
Fluticasone Propionate—Dermatitis—Capecitabine—kidney cancer	6.71e-05	0.000296	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—kidney cancer	6.7e-05	0.000295	CcSEcCtD
Fluticasone Propionate—Headache—Capecitabine—kidney cancer	6.67e-05	0.000294	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—kidney cancer	6.67e-05	0.000294	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCB1—kidney cancer	6.34e-05	0.0159	CrCbGaD
Fluticasone Propionate—Nausea—Capecitabine—kidney cancer	6.32e-05	0.000279	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.25e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—kidney cancer	6.12e-05	0.00027	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—kidney cancer	5.87e-05	0.000259	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—kidney cancer	5.66e-05	0.000249	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—kidney cancer	5.61e-05	0.000247	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—kidney cancer	5.45e-05	0.00024	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—kidney cancer	5.43e-05	0.000239	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—kidney cancer	5.43e-05	0.000239	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—kidney cancer	5.06e-05	0.000223	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—kidney cancer	4.86e-05	0.000214	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—kidney cancer	4.7e-05	0.000207	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—kidney cancer	4.54e-05	0.0002	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—kidney cancer	4.36e-05	0.000192	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—kidney cancer	4.33e-05	0.000191	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—kidney cancer	4.32e-05	0.000191	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—kidney cancer	4.3e-05	0.00019	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—kidney cancer	4.08e-05	0.00018	CcSEcCtD
Fluticasone Propionate—NR3C1—Gene Expression—TCEB2—kidney cancer	3.85e-05	0.000637	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.84e-05	0.000636	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	3.84e-05	0.000635	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SFRP2—kidney cancer	3.79e-05	0.000628	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PDHB—kidney cancer	3.77e-05	0.000624	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—POMC—kidney cancer	3.76e-05	0.000622	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP2—kidney cancer	3.74e-05	0.000619	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKAP13—kidney cancer	3.74e-05	0.000619	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPC3—kidney cancer	3.72e-05	0.000615	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—ANXA1—kidney cancer	3.69e-05	0.00061	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—JUNB—kidney cancer	3.68e-05	0.000609	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.67e-05	0.000607	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.64e-05	0.000602	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	3.63e-05	0.000601	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CA2—kidney cancer	3.62e-05	0.000598	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—CDKN2B—kidney cancer	3.6e-05	0.000595	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.59e-05	0.000594	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CCBL1—kidney cancer	3.55e-05	0.000587	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALAD—kidney cancer	3.53e-05	0.000583	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	3.45e-05	0.000572	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ST3GAL2—kidney cancer	3.44e-05	0.000569	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GRB7—kidney cancer	3.42e-05	0.000566	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.37e-05	0.000557	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALDH1A1—kidney cancer	3.36e-05	0.000556	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CRABP1—kidney cancer	3.34e-05	0.000553	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.29e-05	0.000544	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.26e-05	0.000539	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PGK1—kidney cancer	3.22e-05	0.000533	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC5A3—kidney cancer	3.22e-05	0.000533	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ITPR2—kidney cancer	3.18e-05	0.000527	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LDHB—kidney cancer	3.16e-05	0.000523	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RPL14—kidney cancer	3.13e-05	0.000518	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ITPR2—kidney cancer	3.11e-05	0.000514	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPAT—kidney cancer	3.08e-05	0.000509	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GLIPR1—kidney cancer	3.08e-05	0.000509	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKAP13—kidney cancer	3.06e-05	0.000506	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP2—kidney cancer	3.06e-05	0.000506	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—CDKN2B—kidney cancer	3e-05	0.000496	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3e-05	0.000496	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNA1—kidney cancer	2.89e-05	0.000477	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EIF4EBP1—kidney cancer	2.87e-05	0.000475	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HSPB1—kidney cancer	2.87e-05	0.000475	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.87e-05	0.000474	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—FH—kidney cancer	2.86e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APRT—kidney cancer	2.86e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ACHE—kidney cancer	2.84e-05	0.000469	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTT1—kidney cancer	2.84e-05	0.000469	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GRB7—kidney cancer	2.8e-05	0.000463	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CA9—kidney cancer	2.74e-05	0.000454	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.69e-05	0.000445	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPC3—kidney cancer	2.69e-05	0.000445	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SCARB1—kidney cancer	2.68e-05	0.000444	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TSC1—kidney cancer	2.67e-05	0.000441	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ANXA1—kidney cancer	2.67e-05	0.000441	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PSMD7—kidney cancer	2.67e-05	0.000441	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS1—kidney cancer	2.66e-05	0.00044	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.65e-05	0.000439	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA2—kidney cancer	2.61e-05	0.000433	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PSMD7—kidney cancer	2.61e-05	0.000431	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ITPR2—kidney cancer	2.6e-05	0.00043	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—RAF1—kidney cancer	2.6e-05	0.00043	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FLT1—kidney cancer	2.58e-05	0.000427	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HSPB1—kidney cancer	2.55e-05	0.000422	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	2.55e-05	0.000422	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALAD—kidney cancer	2.55e-05	0.000422	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ST3GAL2—kidney cancer	2.49e-05	0.000411	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.47e-05	0.000409	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—BCHE—kidney cancer	2.47e-05	0.000409	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SLC5A5—kidney cancer	2.44e-05	0.000404	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.44e-05	0.000404	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALDH1A1—kidney cancer	2.43e-05	0.000402	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—kidney cancer	2.41e-05	0.000399	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JUNB—kidney cancer	2.39e-05	0.000396	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PAK1—kidney cancer	2.39e-05	0.000396	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PSMD7—kidney cancer	2.37e-05	0.000392	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNA1—kidney cancer	2.36e-05	0.00039	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SLC2A1—kidney cancer	2.36e-05	0.00039	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.34e-05	0.000388	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EIF4EBP1—kidney cancer	2.34e-05	0.000388	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HSPB1—kidney cancer	2.34e-05	0.000388	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CRABP1—kidney cancer	2.33e-05	0.000386	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PGK1—kidney cancer	2.33e-05	0.000386	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC5A3—kidney cancer	2.33e-05	0.000386	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—IL2—kidney cancer	2.33e-05	0.000385	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.31e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.29e-05	0.000378	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LDHB—kidney cancer	2.29e-05	0.000378	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PSMD7—kidney cancer	2.18e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ANXA1—kidney cancer	2.18e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TSC1—kidney cancer	2.18e-05	0.00036	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ITPR2—kidney cancer	2.17e-05	0.000358	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—JUNB—kidney cancer	2.13e-05	0.000352	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FLT1—kidney cancer	2.11e-05	0.000349	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACY1—kidney cancer	2.06e-05	0.000341	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.99e-05	0.00033	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CA9—kidney cancer	1.98e-05	0.000328	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—kidney cancer	1.98e-05	0.000327	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTT1—kidney cancer	1.98e-05	0.000327	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ACHE—kidney cancer	1.98e-05	0.000327	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTP1—kidney cancer	1.97e-05	0.000325	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MAPK3—kidney cancer	1.96e-05	0.000324	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF2—kidney cancer	1.96e-05	0.000324	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JUNB—kidney cancer	1.96e-05	0.000324	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PAK1—kidney cancer	1.96e-05	0.000324	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN2B—kidney cancer	1.95e-05	0.000322	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—kidney cancer	1.91e-05	0.000316	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1R—kidney cancer	1.89e-05	0.000313	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK3—kidney cancer	1.87e-05	0.00031	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SCARB1—kidney cancer	1.87e-05	0.000309	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ABCB1—kidney cancer	1.86e-05	0.000308	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS1—kidney cancer	1.85e-05	0.000306	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PSMD7—kidney cancer	1.82e-05	0.0003	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—POMC—kidney cancer	1.81e-05	0.000299	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GSTM1—kidney cancer	1.81e-05	0.000299	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK1—kidney cancer	1.78e-05	0.000295	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PDHB—kidney cancer	1.75e-05	0.00029	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—POMC—kidney cancer	1.75e-05	0.000289	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.73e-05	0.000287	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—BCHE—kidney cancer	1.72e-05	0.000285	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CYP1A1—kidney cancer	1.71e-05	0.000283	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.7e-05	0.000281	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CRABP1—kidney cancer	1.68e-05	0.000279	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—kidney cancer	1.68e-05	0.000278	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CCBL1—kidney cancer	1.65e-05	0.000273	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.64e-05	0.000272	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF2—kidney cancer	1.6e-05	0.000265	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—kidney cancer	1.59e-05	0.000263	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ITPR2—kidney cancer	1.57e-05	0.000259	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—kidney cancer	1.56e-05	0.000258	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TSC2—kidney cancer	1.55e-05	0.000257	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1R—kidney cancer	1.55e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—kidney cancer	1.55e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—kidney cancer	1.49e-05	0.000247	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KDR—kidney cancer	1.49e-05	0.000247	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—RAF1—kidney cancer	1.49e-05	0.000246	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.43e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPAT—kidney cancer	1.43e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTT1—kidney cancer	1.43e-05	0.000236	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ACHE—kidney cancer	1.43e-05	0.000236	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.41e-05	0.000233	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.39e-05	0.000231	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—kidney cancer	1.37e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KIT—kidney cancer	1.37e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTP1—kidney cancer	1.37e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SCARB1—kidney cancer	1.35e-05	0.000224	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS1—kidney cancer	1.34e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—kidney cancer	1.34e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APRT—kidney cancer	1.33e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FH—kidney cancer	1.33e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PSMD7—kidney cancer	1.31e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—POMC—kidney cancer	1.31e-05	0.000216	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCB1—kidney cancer	1.3e-05	0.000215	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—kidney cancer	1.29e-05	0.000213	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—POMC—kidney cancer	1.28e-05	0.000211	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—kidney cancer	1.27e-05	0.000211	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TSC2—kidney cancer	1.27e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—kidney cancer	1.26e-05	0.000208	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPC3—kidney cancer	1.25e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—BCHE—kidney cancer	1.24e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.23e-05	0.000203	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—kidney cancer	1.22e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA2—kidney cancer	1.22e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAPK3—kidney cancer	1.19e-05	0.000198	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.19e-05	0.000197	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.19e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALAD—kidney cancer	1.18e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—kidney cancer	1.16e-05	0.000192	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.16e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.13e-05	0.000187	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KIT—kidney cancer	1.12e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—kidney cancer	1.12e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PGK1—kidney cancer	1.08e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.08e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RAF1—kidney cancer	1.08e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK3—kidney cancer	1.07e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RELA—kidney cancer	1.07e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—POMC—kidney cancer	1.07e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—kidney cancer	1.07e-05	0.000176	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LDHB—kidney cancer	1.06e-05	0.000176	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—kidney cancer	1.05e-05	0.000174	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MTOR—kidney cancer	1.05e-05	0.000174	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK1—kidney cancer	1.02e-05	0.000169	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—kidney cancer	1.02e-05	0.000168	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTP1—kidney cancer	9.9e-06	0.000164	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—kidney cancer	9.87e-06	0.000163	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—kidney cancer	9.66e-06	0.00016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—kidney cancer	9.65e-06	0.00016	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—kidney cancer	9.42e-06	0.000156	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JUN—kidney cancer	9.4e-06	0.000155	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCB1—kidney cancer	9.37e-06	0.000155	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—kidney cancer	9.33e-06	0.000154	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA9—kidney cancer	9.21e-06	0.000152	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—kidney cancer	9.1e-06	0.000151	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—kidney cancer	9.09e-06	0.00015	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—POMC—kidney cancer	8.9e-06	0.000147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—kidney cancer	8.88e-06	0.000147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—kidney cancer	8.87e-06	0.000147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RAF1—kidney cancer	8.8e-06	0.000146	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RELA—kidney cancer	8.76e-06	0.000145	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—kidney cancer	8.71e-06	0.000144	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A1—kidney cancer	8.63e-06	0.000143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MTOR—kidney cancer	8.59e-06	0.000142	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—kidney cancer	8.21e-06	0.000136	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—kidney cancer	8.06e-06	0.000133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—kidney cancer	7.89e-06	0.000131	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CRABP1—kidney cancer	7.83e-06	0.00013	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK3—kidney cancer	7.77e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—kidney cancer	7.69e-06	0.000127	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JUN—kidney cancer	7.68e-06	0.000127	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—kidney cancer	7.62e-06	0.000126	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—kidney cancer	7.55e-06	0.000125	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—kidney cancer	7.43e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK1—kidney cancer	7.39e-06	0.000122	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ITPR2—kidney cancer	7.28e-06	0.00012	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—kidney cancer	7.1e-06	0.000117	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—kidney cancer	6.98e-06	0.000115	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK3—kidney cancer	6.9e-06	0.000114	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—kidney cancer	6.72e-06	0.000111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—kidney cancer	6.71e-06	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACHE—kidney cancer	6.64e-06	0.00011	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—kidney cancer	6.64e-06	0.00011	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—POMC—kidney cancer	6.43e-06	0.000106	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—kidney cancer	6.41e-06	0.000106	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK3—kidney cancer	6.34e-06	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SCARB1—kidney cancer	6.29e-06	0.000104	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—kidney cancer	6.26e-06	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS1—kidney cancer	6.22e-06	0.000103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—kidney cancer	6.2e-06	0.000103	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—kidney cancer	6.19e-06	0.000102	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—kidney cancer	6.17e-06	0.000102	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PSMD7—kidney cancer	6.1e-06	0.000101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK1—kidney cancer	6.04e-06	9.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BCHE—kidney cancer	5.79e-06	9.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.71e-06	9.45e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—kidney cancer	5.7e-06	9.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.52e-06	9.13e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—kidney cancer	5.24e-06	8.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—kidney cancer	5.13e-06	8.49e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—kidney cancer	5.07e-06	8.38e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTP1—kidney cancer	4.6e-06	7.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—kidney cancer	4.47e-06	7.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—kidney cancer	4.37e-06	7.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCB1—kidney cancer	4.36e-06	7.21e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—kidney cancer	4.23e-06	7e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.01e-06	6.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—kidney cancer	3.16e-06	5.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—POMC—kidney cancer	2.99e-06	4.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—kidney cancer	2.38e-06	3.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—kidney cancer	2.08e-06	3.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.47e-06	2.43e-05	CbGpPWpGaD
